Vasken Dilsizian and Gerald Pohost, eds
272 pages. Oxford, UK: Blackwell Publishing; 2006. $125.00. ISBN 1–40512–447–4
Major technological advances in computed tomography (CT), positron emission tomography (PET), and magnetic resonance (MR) have propelled imaging, particularly integrated imaging, into the forefront of the management of cardiovascular disease patients. Imaging has become the cornerstone of medical diagnosis, early detection, and treatment. Although CT and MR imaging provide exquisite morphological and pathological details, PET explores pathophysiological alterations. In the book Cardiac CT, PET and MR, Drs Dilsizian and Pohost, along with a group of highly accomplished investigators, deliver timely and comprehensive information on advanced cardiovascular imaging techniques. Both editors are leaders and outstanding educators in the field of noninvasive imaging with a wealth of clinical experience.
Cardiac CT, PET and MR is divided into 3 sections. The first section is organized according to the instrumentation, imaging techniques, and protocols for each of the imaging modalities: PET, MR, and multidetector (as well as electron-beam) CT. These chapters provide easy-to-understand physics and an evolution of these technologies. The second section is organized according to the clinical applications of each of the imaging modalities for the assessment of coronary arteries and great vessels and of myocardial perfusion, function, viability, and innervation. Each of the clinically oriented chapters begins with a succinct overview of clinical and imaging issues followed by a comprehensive review of currently published literature. The last section of the book provides concurrent assessments of coronary anatomy, physiology, and myocellular integrity. The book concludes with an interesting chapter by Henning and Dilsizian on trends and new developments in integrated PET/CT and single photon emission tomography/CT systems. The organization of the last section reflects the editors’ emphasis on physiology over and above a more commonly practiced morphology-based description of coronary artery disease. These technological advances, which have so remarkably enhanced our capacity for accurate diagnosis and management, have also raised a number of perplexing questions. How, which, and in what sequence should such procedures be used? It is with considerations such as these that make this text essential for practicing cardiologists and radiologists. The book will promote a better understanding and thus an improved utilization of these noninvasive techniques for the benefit of patients.
The uniformity of the tables, figures, and illustrations along with masterful editing of the chapters make the monograph seamless, as though it was written by a single author. In this regard, the book departs from other multi-author books where stylistic differences in writing as well as author-specific display of illustrations, figures, and colors make books a mere collection of articles, similar to those published from proceedings, rather than a well-edited monograph. The quality of the photographs and illustrations are excellent. The figures are not cluttered with excessive use of arrows and other notation. The references have been carefully selected to blend both historically essential references along with recent publications in journals.
This is an exciting time for cardiovascular imaging. The anatomic accuracy of noninvasive coronary artery lesion detection, along with physiological and metabolic correlates of myocardial function, are far better than they have been previously. Likewise, it is the perfect time to bring forth a book like this, which is dedicated to both advanced cardiovascular imaging as well as the integration of information from combined imaging modalities to derive at a more accurate and comprehensive clinical assessment. Summarily, these features render this monograph indispensable.
Sources of Funding
Dr Narula has received imaging research grants from the National Institute of Health.
Dr Narula has served on the speakers bureau for and received honoraria from GlaxoSmithKline and Toshiba and served as a consultant for BMS and General Electric.